ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,022Medicare Part D Prescriptions Filled, Including Refills

Rank: 26 out of 229

$587K Total Retail Price of All Prescriptions

Rank: 33 out of 229

608 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
80% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 608 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

6% of this provider’s 608 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 8,920 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
LEVOTHYROXINE SODIUM 510 429 1 1
LISINOPRIL 498 415 2 2
FUROSEMIDE 409 323 3 8
WARFARIN SODIUM 375 297 4 17
OMEPRAZOLE 336 261 5 4
CITALOPRAM HBR 325 257 6 21
METOPROLOL TARTRATE 294 235 7 13
SIMVASTATIN 268 246 8 3
KLOR-CON M20 252 183 9 91
AMLODIPINE BESYLATE 234 207 10 5
MIRTAZAPINE 233 202 11 52
DONEPEZIL HCL 225 220 12 29
GABAPENTIN 215 144 13 10
CYMBALTA 198 169 14 64
LANTUS 161 143 15 40
METFORMIN HCL 155 141 16 6
SERTRALINE HCL 132 98 17 22
TAMSULOSIN HCL 128 111 18 24
DIVALPROEX SODIUM 115 76 19 132
HYDROCHLOROTHIAZIDE 113 96 20 9
LOSARTAN POTASSIUM 107 102 21 12
FLUTICASONE PROPIONATE 104 74 22 23
ATENOLOL 99 82 23 19
FAMOTIDINE 98 62 24 84
NAMENDA 93 90 25 39
PRAZOSIN HCL 91 80 26 201
SPIRONOLACTONE 88 84 27 56
CIPROFLOXACIN HCL 85 71 28 58
NOVOLOG 85 81 28 116
ALENDRONATE SODIUM 84 81 30 14
OXYBUTYNIN CHLORIDE ER 83 66 31 80
HYDROCODONE-ACETAMINOPHEN 80 56 S3 32 7
ENOXAPARIN SODIUM 78 40 33 252
LEVETIRACETAM 75 49 34 177
ATORVASTATIN CALCIUM 75 55 34 15
PANTOPRAZOLE SODIUM 75 65 34 33
NOVOLIN R 72 69 37 164
KLOR-CON M10 72 53 37 161
METOPROLOL SUCCINATE 71 69 39 16
GLIPIZIDE 69 64 40 36
RISPERIDONE 69 68 40 95
MELOXICAM 68 67 42 45
OXYBUTYNIN CHLORIDE 67 47 43 97
LOVASTATIN 66 50 44 11
OLANZAPINE 66 62 44 109
ESCITALOPRAM OXALATE 64 41 46 98
QUETIAPINE FUMARATE 63 53 47 90
CARVEDILOL 60 42 48 31
FINASTERIDE 59 51 49 55
HYDROXYZINE HCL 57 54 R 50 165
PREDNISONE 56 40 51 35
PAROXETINE HCL 52 48 52 49
NYSTATIN 52 43 52 233
HEPARIN SODIUM 52 45 52 293
NITROFURANTOIN MONO-MACRO 52 40 52 293
TRAZODONE HCL 52 42 52 34
POTASSIUM CHLORIDE 51 49 57 18
CARBIDOPA-LEVODOPA 50 31 58 82
PHENYTOIN SODIUM EXTENDED 50 39 58 136
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 15, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.